Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16588474 | 0.92 | SRC (0.41) | MEN1KMT2AL3MBTL1ALDH1A1PKM | |
| SCHEMBL13430901 | 0.92 | CYP3A4 (0.43) | — | |
| SCHEMBL13430898 | 0.91 | CA1 (0.46) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL1726069 | 0.87 | MEN1 (0.56) | MEN1KMT2AL3MBTL1ALDH1A1PKM | |
| SCHEMBL13430907 | 0.87 | BTN3A1 (0.41) | MEN1KMT2AL3MBTL1PKM | |
| SCHEMBL16597528 | 0.85 | SRC (0.36) | MEN1KMT2AL3MBTL1ALDH1A1PKM | |
| SCHEMBL13430900 | 0.85 | ANPEP (0.39) | MEN1KMT2AL3MBTL1PKM | |
| SCHEMBL1726270 | 0.84 | MEN1 (0.56) | MEN1KMT2AL3MBTL1PKM | |
| SCHEMBL13430906 | 0.83 | L3MBTL1 (0.38) | MEN1KMT2AL3MBTL1ALDH1A1PKM | |
| SCHEMBL16581628 | 0.82 | LPAR3 (0.47) | L3MBTL1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2097428-B1 | BUTYRYLCHOLINESTERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | MGP BIOTECHNOLOGIES INC (US) | 2018-02-28 | — | — | EP | disclosed |